InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Dugan Margaret, Director. Director active across 3 companies, notably BeiGene, Ltd.. Aggregated, 9 reports have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €81k. History available since 22 June 2022. The latest transaction was filed on 22 May 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
9 of 9 declarations
Margaret Dugan serves as a Board Member at BeiGene, Ltd. In this role, she is involved in overseeing the company's operations and defining its strategy. BeiGene, Ltd. is a biopharmaceutical company focused on research and development. Margaret brings her experience in corporate governance to the board.